For his 16th novel, the author has left behind his comfort zone by setting the book not in the past but the near future
), and psychiatry . Now, for his 16th novel, he’s thrown a curveball, and turned to the future, and to science fiction.sci-fi, which still conjures up images of spaceships and Captain Kirk asking of Scotty whether he can “beam me up”. Instead,is more speculative fiction, concerning a likely tomorrow so close you can almost reach out and touch it.
An institute that specialises in IVF treatment brings the three together, ostensibly to give each what they want: an injection of cash for the former in exchange for surrogacy; a baby for the latter. But the institute, run by a tech billionaire disruptor – think Elon Musk, but in skinnier jeans – has other plans, ones that play with the boundaries of ethics.
Faulks crams in an awful lot of science here, which he is at pains to convey to the reader. “Walk me through it again,” the billionaire says to his team of scientists. “Tell me as if to a kid.” Seth is only part Neanderthal; otherwise, he’s one of us. He “passes”. “He was shorter and stockier than most,” Faulks writes. “His heavy forehead and dark eyebrows made it look as if he was thinking things through carefully, though his weak chin suggested it was unlikely he’d reach much of a conclusion.” Seth, he tells us, looks “a wee bit like Lionel Messi.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NGS-based screening identifies rare and novel thalassemia mutations in Ganzhou, ChinaAround 5.2% of the global population carries abnormal hemoglobin genes. Each year, 300,000 to 500,000 children are born with severe hemoglobinopathies worldwide, with approximately 80% of these cases occurring in developing countries.
Read more »
Zadie Smith’s historical novel deals with current issuesElite men who delude the masses are just one of the new book’s many strands
Read more »
- a game-changing novel antibiotic with no resistanceResearchers reported the discovery of a new antibiotic, clovibactin.
Read more »
Belfast author on being nominated for prestigious award for his debut novelMichael Magee's debut novel Close To Home narrowly missed out on the Waterstones debut novel of the year award
Read more »
MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodiesThe University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.
Read more »